WorstPills.org - your expert, independent second opinion for prescription drug information

Free Health Tips

Cut your prescription bill Limit your side effects Learn about generics

For Subscribers

Drug reviews
Warnings
Safer alternatives

Recent activism

Protecting patient's rights to sue drug companies

Petitioning for stronger warnings on Fluoroquinolone antibiotics
Get involved with Public Citizen today!

Drug Information Search

Last Search


Advanced Search (Search by drug family, disease or side effect)

Worst Pills, Best Pills Articles - November 2009
A Review of Exenatide (BYETTA) for Type-2 Diabetes Middle Ear Infections and Antibiotic Use in Children New Gout Drug Februxostat (ULORIC) has Important Drug Interactions An Update on the HPV Vaccine Gardasil

Recent Drug News - Free

From Public Citizen
Oxycodone: Be Careful What You Take With It A Review of Shingles Vaccine ZOSTAVAX Swine Flu: Important Advice from WorstPills.org 136 Drugs Can Cause Cognitive Impairment FDA Committee Confirms Darvon’s Risks Outweigh Benefits

In the Media
White House Negotiations With Pharmaceutical Industry Dr. Wolfe Discusses Acetaminophen on NPR Online Age Quiz is a Window for Drug Makers A Silenced Drug Study Creates an Uproar Pharmacies’ Data on Drugs often Varies

Free content
   Public Citizen sues FDA to get Darvon removed from market
   62 Prescription Drugs that can cause Eye Disease
   Drug companies, FDA lagged in warning public about Zetia, Vytorin
   Many drugs we designated as "Do Not Use" withdrawn from market

Questions? Visit our FAQ
Have you suffered an adverse drug reaction? Report it to the FDA

Talk to your doctor before changing your drug regimen. Public Citizen is a non-profit organization. To ensure our independence, we take no corporate or government contributions and we accept no advertising.

Subscriber Login

Email:

Password:

Forgot password?

Why Subscribe?

Our doctors and pharmacists analyze the FDA's own data so you get the second opinion you need. Read more>>

See a Sample
Access our subscriber-only information on ADVAIR at no cost (PDF)